Business Context and Reporting Period
Company: Cree Research, Inc. (Note: The filing metadata lists "WOLFSPEED, INC.", but the document text identifies the registrant as Cree Research, Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and six months ended December 28, 1997.
Business Overview: The company manufactures light-emitting diodes (LEDs), wafer materials, and display products. It also engages in research and development, often funded by U.S. government contracts. The company recently changed its fiscal year to a 52/53-week year ending on the last Sunday in June.
Key Financial Metrics
| Metric | Three Months Ended Dec 28, 1997 | Six Months Ended Dec 28, 1997 | Six Months Ended Dec 31, 1996 |
|---|---|---|---|
| Total Revenue | $10,106,000 | $20,313,000 | $13,528,000 |
| Net Income | $1,472,000 | $2,640,000 | $2,264,000 |
| Diluted EPS | $0.11 | $0.20 | $0.17 |
| Gross Margin (Product) | 39% | 37% | 29% (Prior Year) |
| Operating Cash Flow (6mo) | $2,820,000 | ||
| Cash and Equivalents (End of Period) | $13,102,000 | ||
| Long-Term Debt | $3,259,000 |
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 55% for the quarter and 50% for the six-month period compared to the prior year. Excluding a one-time $2.6 million license fee in the prior year, revenue growth for the six-month period was 86%.
- Product Revenue: Product revenue surged 79% (quarter) and 124% (six months), driven primarily by a 116% increase in LED sales due to volume shipments under a contract with Siemens AG.
- Profitability: Net income rose significantly, aided by improved gross margins (39% vs. 29% prior year quarter) resulting from higher throughput and manufacturing yields.
- Debt and Liquidity: The company incurred $3.26 million in long-term debt to finance the purchase of a new production facility. Cash and cash equivalents increased from $10.4 million to $13.1 million.
- One-Time Items: The company recorded a $66,000 write-off of goodwill related to the Real Color Displays subsidiary. It also received $436,000 in insurance reimbursements related to legal defense and medical expenses.
Guidance, Outlook, and Risks
- Siemens Contract: A second amendment to the Siemens agreement obligates the company to ship LED chips with a fixed contract price exceeding $6 million for the remainder of fiscal 1998. However, the contract stipulates declining average sales prices as volume increases.
- Cost Reduction Strategy: Management emphasizes the critical need to lower unit costs to maintain margins amidst declining sales prices. Strategies include transitioning to two-inch wafers and a new "conductive buffer" LED technology expected to be 50% brighter and cheaper to produce.
- Capital Expenditures: The company is investing approximately $9–10 million in a new facility in Durham, NC. Financing is secured via a $10 million term loan (8% interest), with $6.7 million remaining available.
- Risks: Key risks include the inability to achieve projected cost reductions, delays in new product introductions, customer acceptance of new technologies, and reliance on a limited customer base for LED sales.
- Legal: Consolidated securities class action lawsuits were dismissed with prejudice in November 1997 with no payment to plaintiffs.
Investor Verification Checklist
- Siemens Volume vs. Price: Verify if the volume increases under the Siemens contract are sufficient to offset the mandated price reductions to sustain the 37-39% gross margin.
- Cost Reduction Execution: Confirm the timeline and success of the transition to two-inch wafers and the conductive buffer technology, as these are critical to future profitability.
- Debt Covenants: Review the specific covenants of the $10 million term loan, particularly the minimum tangible net worth requirement, to ensure compliance.
- Customer Concentration: Assess the risk associated with reliance on Siemens for a significant portion of LED revenue and the progress in diversifying the customer base.
- Government Funding: Monitor the status of U.S. government research contracts, as the mix of cost-share vs. cost-plus arrangements impacts revenue recognition and R&D expense classification.